Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Deprescribing to Improve Patient Care & Quality of Life



Speaker
Sara Rogers, Pharm.D., BCPS
Clinical Assistant Professor
Texas A&M University 

Learning Objectives 
  • Explain deprescribing and its purpose in practice.
  • Identify which patients and medications are good candidates for deprescribing.
  • Discuss the stepwise approach to safe and effective deprescribing.

Instructions
This program consists of one video and downloadable resources in PDF format.
 
To begin, scroll to the bottom of this page and click the green "Purchase Now" button. You will then be asked to log in or create an account. If you have taken a course with UT Pharmacy CE previously, be sure to use the same login as before. Once you are logged in, you can complete the registration and then take the course. After you have registered, you will be able to access this course at any time until the expiration date. 
 
Speaker information and disclosures can be found in the tab below.   

Fee

$20.00

CE Hours

1.25

CE Units

0.125

Activity Type

  • Knowledge

Support/Credits

Continuing Education Credit
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.10 CEUs (1.00 contact hour) of continuing education credit. To receive 1.00 contact hour of CE credit, the participant must watch the included video in its entirety, pass the online post-test ( >70% within 5 attempts), and complete the online evaluation. Upon successfully completing the course evaluation, the continuing pharmacy education credits will automatically be uploaded to CPE Monitor (allow 3-7 days).
 

 

 

 

Deprescribing to Improve Patient Care & Quality of Life
 
About the Speaker
Sara Rogers, Pharm.D., BCPS
Clinical Assistant Professor
Texas A&M University  
 
Sara Rogers serves as Clinical Assistant Professor of Precision Medicine and Ambulatory Care at Irma Lerma Rangel College of Pharmacy, Texas A&M University and Clinical Specialist at Texas A&M Physicians Clinic. She co-founded the American Society of Pharmacovigilance, where she led the Society’s clinical, research and educational initiatives. Rogers co-led the formation of the Pharmacogenomics Access and Reimbursement Coalition and collaboratively developed the Coalition’s research agenda to understand the payment and policy landscape for pharmacogenetics testing and its role in disparities in patient access. Rogers serves as an organizational member of the NIH National Human Genomics Research Institute Inter-Society Coordinating Committee and develops educational resources to help practitioners navigate coverage for pharmacogenetics testing. Her research track record reveals a long-standing goal of informing policy and practice. Dr. Rogers has served as co-investigator for a pilot study to identify ethical values and priorities related to pharmacogenomics. Her research focuses extensively on patient access to and reimbursement for pharmacogenetics testing. Rogers co-led the formation of the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community, a public-private multidisciplinary initiative to develop consensus-based industry standards for pharmacogenetics testing. Prior to serving in these roles, Rogers was an Ambulatory Treatment Center pharmacist at MD Anderson Cancer Center where she led team-based research projects to optimize workflow and screening protocols throughout the division of pharmacy.
Disclosure: Sara Rogers does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

Activity Number

0067-0000-22-069-H04-P/T

Release Date: Sep 24, 2022
Credit Expiration Date: Sep 24, 2025

CE Hours

1.25